# Emergency Assistance Japan Co., Ltd.: business model and financials

> Latest period: FY ending Dec 2025, consolidated, J-GAAP
> Unit: JPY millions
> Sources: 有価証券報告書－第23期(2025/01/01－2025/12/31) (S100XUYQ)
> Page: https://vizora.meequs.com/en/company/emergency-assistance-japan
> Retrieved: 2026-09-30T20:42:15.997Z

## Company

Emergency Assistance Japan, founded in 2005, is a company in Business Process Outsourcing listed on TSE Standard. It has 247 employees (consolidated).

| Field | Value |
| --- | ---: |
| Legal name | Emergency Assistance Japan Co., Ltd. |
| Ticker | 6063 |
| Stock price | View on Yahoo Finance (https://finance.yahoo.co.jp/quote/6063.T) |
| Listing | TSE Standard |
| Head office | 東京都文京区小石川一丁目21番14号 |
| Representative (per filing) | 代表取締役社長 山本 秀樹 |
| Founded | Jun 2005 |
| Share capital | ¥312M |
| Employees (consolidated) | 247 |
| Average salary (parent only) | ¥5.2M |
| Fiscal year end | December |
| Website | www.emergency.co.jp (https://www.emergency.co.jp/) |
| Corporate number | 8010001081502 |
| EDINET | E26625 |
| Industries (Vizora) | Business Process Outsourcing |

> Profile source: annual securities report (S100XUYQ, filed 2026-03-27). As of filing

## Five-axis industry profile

Primary industry: Business Process Outsourcing (2025-12-31)

| Axis | Industry percentile | Peers |
| --- | ---: | ---: |
| Revenue growth | 58.3 | 18 |
| Profitability | 35.7 | 21 |
| Cash conversion | 91.2 | 17 |
| Efficiency | 26.2 | 21 |

Each axis is shown independently. Missing values are labeled unavailable; no combined score is calculated. Industry rank is not an investment recommendation.

## Key points (generated from figures)

- About 87% of Emergency Assistance Japan's sales come from Medical assistance department, with Life assitance department making up much of the rest.
- Out of every ¥100 of sales, about ¥3 is left as operating profit.
- Revenue changed +27.7% from the prior year, operating profit +84.2%.

## Company structure

- Segment revenue mix: Medical assistance department 87.0%、Life assitance department 13.0%
- Revenue → net income: ¥3714674000 → ¥101886000
- Net income → operating cash flow: ¥101886000 → ¥295748000（difference ¥193862000）
- Main uses of operating cash flow: CapEx ¥37246000 / dividends ¥19436000 / buybacks ¥43000
- Change in cash: ¥115657000
Segment shares use total reported segment revenue, which may include inter-segment sales. The cash bridge is operating cash flow minus net income and combines non-cash items and working-capital effects.

## Key figures at a glance

| Metric | Value | Note |
| --- | ---: | ---: |
| Revenue | ¥3.71B |  |
| Operating income | ¥96.1M | Margin 2.6% |
| Net income | ¥101.9M | Margin 2.7% |
| Free cash flow | ¥258.5M |  |
| Largest business | Medical assistance department | of segment revenue 87.0% |
| Employees (consolidated) | 247 |  |
| EPS | ¥37.69 |  |
| Book value per share | ¥533.61 |  |
| Equity ratio | 48.7% |  |
| Shares outstanding | 2,519,600 |  |
| Treasury shares | 400 |  |
| Shareholders | 1,302 |  |
| Average salary (parent only) | ¥5.2M | Filing company only |
| Cash ratio | 59.8% | Cash ÷ revenue 61.4% |
| Vs. industry median margin | -1.3 pp | Business Process Outsourcing |
| ROE | 6.3% | Derived from disclosed figures |
| ROA | 2.7% | Derived from disclosed figures |

## Notable figures

- FY2025, operating cash flow is 2.9× net income
- FY2025, one segment accounts for 82% of positive segment profit
- FY2025, cash is 60% of total assets

## What changed in 5 years

| Metric | FY ending Dec 2020 | FY ending Dec 2025 | Change |
| --- | ---: | ---: | ---: |
| Revenue | ¥2251279000 | ¥3714674000 | +65.0% |
| Operating income | ¥17362000 | ¥96111000 | +453.6% |
| Operating margin | 0.8% | 2.6% | +1.8 pp |
| Employees | 279 people | 247 people | -11.5% |
| Cash and equivalents | ¥1580416000 | ¥2279415000 | +44.2% |

### Change in segment revenue mix

Span: FY ending Dec 2020 → FY ending Dec 2025. Stable segment keys are connected; unmatched shares are marked as new or reorganized. Shares use total segment revenue.

| Flow | Revenue share |
| --- | ---: |
| 医療アシスタンス事業 → 医療アシスタンス事業 | 74.4% |
| ライフアシスタンス事業 → ライフアシスタンス事業 | 13.0% |
| ライフアシスタンス事業 → 事業再編・廃止 | 12.6% |
| 新設・再編 → 医療アシスタンス事業 | 12.6% |

Segment revenue source references: 4 (derived)

## Income statement（FY ending Dec 2025, consolidated, J-GAAP）

| Item | Amount (JPY mn) | % of revenue | Source |
| --- | ---: | ---: | ---: |
| Revenue | 3,715 | 100.0% | S100XUYQ |
| Cost of revenue | 2,843 | 76.5% | S100XUYQ |
| Gross profit | 872 | 23.5% | S100XUYQ |
| SG&A | 776 | 20.9% | S100XUYQ |
| Operating income | 96 | 2.6% | S100XUYQ |
| Ordinary income | 104 | 2.8% | S100XUYQ |
| Pretax income | 121 | 3.3% | S100XUYQ |
| Income tax | 19 | 0.5% | S100XUYQ |
| Net income | 102 | 2.7% | S100XUYQ |
| Net income attributable to owners | 102 | 2.7% | S100XUYQ |

## Per ¥100 of revenue（FY ending Dec 2025）

| Part | JPY |
| --- | ---: |
| Cost of revenue | 76 |
| SG&A | 21 |
| Operating income | 3 |
| (Ref.) Net income | 3 |

### Margin funnel

Gross margin 23.5% → Operating margin 2.6% → Net margin 2.7%
Derived from reported figures (DERIVED).

## Revenue and profit pattern

Pattern: Revenue and profit up
Revenue growth: +27.7%; Core profit growth: +84.2%
Growth quality: margin-expansion
Operating leverage (core profit growth ÷ revenue growth): 3.04×
Calculated from comparable annual consolidated filings.

## Year over year（FY ending Dec 2024 → FY ending Dec 2025、JPY mn）

| Metric | Prior | Current | Change | % change |
| --- | ---: | ---: | ---: | ---: |
| Revenue | 2,909 | 3,715 | 806 | +27.7% |
| Gross profit | 800 | 872 | 72 | +9.0% |
| Operating income | 52 | 96 | 44 | +84.2% |
| Net income attributable to owners | 48 | 102 | 54 | +112.2% |
| Operating cash flow | -40 | 296 | 336 | — |
| Free cash flow | -89 | 259 | 348 | — |

## History（JPY mn）

| Period | Revenue | Op. income | Op. margin | Net income | Op. CF | FCF | Source |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| FY ending Dec 2019 | 2,959 | 94 | 3.2% | 63 | -38 | -135 | S100L1RH |
| FY ending Dec 2020 | 2,251 | 17 | 0.8% | -0 | 405 | 389 | S100NR73 |
| FY ending Dec 2021 | 4,359 | 236 | 5.4% | 179 | -245 | -265 | S100QGHJ |
| FY ending Dec 2022 | 6,241 | 717 | 11.5% | 500 | 920 | 854 | S100T5VS |
| FY ending Dec 2023 | 3,599 | 173 | 4.8% | 120 | -5 | -31 | S100VIOQ |
| FY ending Dec 2024 | 2,909 | 52 | 1.8% | 48 | -40 | -89 | S100XUYQ |
| FY ending Dec 2025 | 3,715 | 96 | 2.6% | 102 | 296 | 259 | S100XUYQ |

## People and productivity（FY ending Dec 2025, consolidated, J-GAAP）

| Metric | Value |
| --- | ---: |
| Revenue per employee (consolidated) | ¥15M |
| Operating income per employee (consolidated) | ¥389.1K |
| Net income per employee (consolidated) | ¥412.5K |

Employees, revenue and profit are consolidated. Average annual salary is a separate parent-company figure. Calculated from disclosed figures (DERIVED).

| History | FY ending Dec 2021 | FY ending Dec 2022 | FY ending Dec 2023 | FY ending Dec 2024 | FY ending Dec 2025 |
| --- | ---: | ---: | ---: | ---: | ---: |
| Employees (consolidated) | 251 | 234 | 229 | 229 | 247 |
| Average salary (parent company) | ¥5.1M | ¥5.3M | ¥5.1M | ¥5.1M | ¥5.2M |
| Average age (parent company) | 41.4 years | 42.6 years | 43.8 years | 44.0 years | 44.0 years |
| Average tenure (parent company) | 7.4 years | 8.2 years | 8.7 years | 8.6 years | 8.3 years |

Year over year: Employees (consolidated) +7.9% · Revenue (consolidated) +27.7%

## Segments（FY ending Dec 2025, consolidated, J-GAAP、JPY mn）

| Segment | Revenue | Share | Op. income | Op. margin |
| --- | ---: | ---: | ---: | ---: |
| Medical assistance department | 3,230 | 87.0% | 516 | 16.0% |
| Life assitance department | 484 | 13.0% | 114 | 23.6% |

### segmentMix — Revenue and profit mix

Calculated from disclosed figures (DERIVED). Shares use total segment revenue and total positive segment profit respectively. Difference = profit share − revenue share (pt). Inter-segment sales may prevent reconciliation to company revenue.

| Segment | Revenue share | Profit share | Difference (pt) | Margin |
| --- | ---: | ---: | ---: | ---: |
| Medical assistance department | 87.0% | 81.9% | -5.1 | 16.0% |
| Life assitance department | 13.0% | 18.1% | 5.1 | 23.6% |

Segment → industry: Life assitance department → Business Process Outsourcing / Medical assistance department → Business Process Outsourcing

## Revenue by geography

No geographic revenue breakdown was disclosed.

## Cash flow（FY ending Dec 2025, consolidated, J-GAAP）

| Item | Amount (JPY mn) | % of revenue | Source |
| --- | ---: | ---: | ---: |
| Operating cash flow | 296 | 8.0% | S100XUYQ |
| Capital expenditure | 37 | 1.0% | S100XUYQ |
| Free cash flow | 259 | 7.0% | 算出 |
| Investing cash flow | -86 | -2.3% | S100XUYQ |
| Financing cash flow | -119 | -3.2% | S100XUYQ |
| Dividends paid | 19 | 0.5% | S100XUYQ |
| Share buyback | 0 | 0.0% | S100XUYQ |
| Change in cash | 116 | 3.1% | S100XUYQ |
| Cash and equivalents | 2,279 | 61.4% | S100XUYQ |

## Balance sheet

Figures are as of each fiscal year end. Derived values are marked as such in the source column. Lease liabilities are excluded from interest-bearing debt.

| Metric | FY ending Dec 2021 | FY ending Dec 2022 | FY ending Dec 2023 | FY ending Dec 2024 | FY ending Dec 2025 | Source |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | 1,709 | 2,302 | 2,189 | 2,164 | 2,279 | S100T5VS, S100VIOQ, S100XUYQ |
| Total assets | 3,803 | 3,933 | 3,685 | 3,808 | 3,814 | S100QGHJ, S100T5VS, S100VIOQ, S100XUYQ |
| Net assets | 1,081 | 1,606 | 1,714 | 1,803 | 1,887 | S100T5VS, S100VIOQ, S100XUYQ |
| Share capital | 312 | 312 | 312 | 312 | 312 | S100QGHJ, S100T5VS, S100VIOQ, S100XUYQ |
| Property, plant and equipment | 108 | 100 | 84 | 68 | 65 | S100QGHJ, S100T5VS, S100VIOQ, S100XUYQ |
| Intangible assets excluding goodwill | 46 | 53 | 56 | 67 | 59 | S100QGHJ, S100T5VS, S100VIOQ, S100XUYQ |
| Current assets | 3,562 | 3,693 | 3,460 | 3,574 | 3,608 | S100QGHJ, S100T5VS, S100VIOQ, S100XUYQ |
| Current liabilities | 2,681 | 2,299 | 1,938 | 1,974 | 1,901 | S100QGHJ, S100T5VS, S100VIOQ, S100XUYQ |
| Short-term borrowings | 1,380 | 1,110 | 1,080 | 1,180 | 1,080 | S100QGHJ, S100T5VS, S100VIOQ, S100XUYQ |
| Long-term borrowings | 20 | 8 | — | — | — | S100QGHJ, S100T5VS |
| Total liabilities | 2,722 | 2,327 | 1,971 | 2,004 | 1,927 | S100QGHJ, S100T5VS, S100VIOQ, S100XUYQ |
| Equity attributable to owners of parent | 1,011 | 1,485 | 1,547 | 1,583 | 1,665 | S100QGHJ, S100T5VS, S100VIOQ, S100XUYQ |
| Retained earnings | 498 | 972 | 1,034 | 1,070 | 1,152 | S100QGHJ, S100T5VS, S100VIOQ, S100XUYQ |
| Treasury stock | -0 | -0 | -1 | -1 | -1 | S100QGHJ, S100T5VS, S100VIOQ, S100XUYQ |

### Assets and funding mix

| Assets | Share | Source |
| --- | ---: | ---: |
| Cash | 60% | S100XUYQ |
| Property, plant and equipment | 2% | S100XUYQ |
| Intangibles and goodwill | 1% | S100XUYQ |
| Other assets | 37% | S100XUYQ |

| Funding source | Share | Source |
| --- | ---: | ---: |
| Other liabilities | 51% | S100XUYQ |
| Equity | 49% | S100XUYQ |

### Balance sheet history

| Metric | FY ending Dec 2021 | FY ending Dec 2022 | FY ending Dec 2023 | FY ending Dec 2024 | FY ending Dec 2025 |
| --- | ---: | ---: | ---: | ---: | ---: |
| Total assets | 3,803 | 3,933 | 3,685 | 3,808 | 3,814 |
| Equity | 1,081 | 1,606 | 1,714 | 1,803 | 1,887 |
| Interest-bearing debt | — | — | — | — | — |
| Cash | 1,709 | 2,302 | 2,189 | 2,164 | 2,279 |

## Asset intensity and goodwill

Ratios are derived from reported values. Goodwill is used only when separately reported, never inferred from combined intangible assets.

| Metric | Value | Sources |
| --- | ---: | ---: |
| Asset intensity (fixed assets ÷ revenue) | 1.8% | S100XUYQ |
| Fixed assets ÷ total assets | 1.7% | S100XUYQ |
| Goodwill ÷ parent equity | — | —, S100XUYQ |

### Cash quality

Net cash = cash − interest-bearing debt. Net debt ratio = (interest-bearing debt − cash) ÷ positive operating cash flow. Omit when debt components are incomplete; other ratios are derived from reported figures.

| Metric | Value |
| --- | ---: |
| Cash ratio (cash ÷ total assets) | 59.8% |
| Cash ÷ revenue | 61.4% |
| Net cash (cash − interest-bearing debt) | — |
| Net debt ÷ operating cash flow | — |
| Cash conversion (operating CF ÷ operating income) | 307.7% |
| Cash vs. profit gap | 194 JPY mn (of net income 190.3%) |
| Shareholder returns / net income | 19.1% |
| Shareholder returns / FCF | 7.5% |
| Shareholder payments — dividends / net income | 19.1% |
| Shareholder payments — dividends / FCF | 7.5% |
| CapEx intensity (capex ÷ revenue) | 1.0% |
| Investing CF relative to operating CF | 29.0% |

## ROA and ROE

ROE is decomposed into net margin × asset turnover × financial leverage. Leverage can raise ROE, so the ratio alone does not assess a company's condition. Ending balances are used without a prior year; total equity approximates parent equity when unavailable.

| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE | Sources |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| 2021 | 4.1% | 1.15× | 4.7% | 3.76× | 17.7% | S100QGHJ |
| 2022 | 8.0% | 1.61× | 12.9% | 3.10× | 40.1% | S100T5VS |
| 2023 | 3.3% | 0.94× | 3.1% | 2.51× | 7.9% | S100VIOQ |
| 2024 | 1.7% | 0.78× | 1.3% | 2.39× | 3.1% | S100XUYQ |
| 2025 | 2.7% | 0.97× | 2.7% | 2.35× | 6.3% | S100XUYQ |

## Ownership

| Counterparty | Relation | Ratio | As of |
| --- | ---: | ---: | ---: |
| 徐志敏 | Major shareholder | 12.8% | 2025-12-31 |
| ヴァンタークルーズヘルスサービスインク （常任代理人 吉田 幸子） | Major shareholder | 7.2% | 2025-12-31 |
| 徐宏沢 | Major shareholder | 6.8% | 2025-12-31 |
| 徐雲沢 | Major shareholder | 4.5% | 2025-12-31 |
| 氷鉋健一郎 | Major shareholder | 3.1% | 2025-12-31 |
| 徐慧明 | Major shareholder | 2.8% | 2025-12-31 |
| 舞原満博 | Major shareholder | 2.1% | 2025-12-31 |
| 張麗玲 | Major shareholder | 2.0% | 2025-12-31 |
| 廣崎双葉 | Major shareholder | 1.6% | 2025-12-31 |
| 吉田幸子 | Major shareholder | 1.5% | 2025-12-31 |

## Sources

| Document | ID | Published | URL |
| --- | ---: | ---: | ---: |
| 有価証券報告書－第23期(2025/01/01－2025/12/31) | S100XUYQ | 2026-03-27 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XUYQ,, |
| 有価証券報告書－第22期(2024/01/01－2024/12/31) | S100VIOQ | 2025-03-28 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100VIOQ,, |
| 有価証券報告書－第21期(2023/01/01－2023/12/31) | S100T5VS | 2024-03-28 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100T5VS,, |
| 有価証券報告書－第20期(2022/01/01－2022/12/31) | S100QGHJ | 2023-03-27 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100QGHJ,, |
| 有価証券報告書－第19期(令和3年1月1日－令和3年12月31日) | S100NR73 | 2022-03-28 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100NR73,, |
| 有価証券報告書－第18期(令和2年1月1日－令和2年12月31日) | S100L1RH | 2021-03-26 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100L1RH,, |

## Definitions

- Amounts are in millions of JPY (rounded). The period is stated in each table heading
- Operating margin = operating income ÷ revenue. Net income is attributable to owners of the parent when disclosed
- Free cash flow (FCF) = operating cash flow − capital expenditure
- ¥100 model = breakdown per ¥100 of revenue (rounded so parts sum to 100)
- Segment revenues include inter-segment sales and may not sum to consolidated revenue
- Source IDs are EDINET document IDs (docID). "算出" (derived) means computed from other disclosed values
- All figures are extracted mechanically from filings. AI-written text never generates figures
- Source: company filings submitted to EDINET (Financial Services Agency of Japan). Figures were extracted, edited and processed, and charts and text were created, by Vizora — not by the FSA (used under the Public Data License v1.0).